| OPDIVO 10 mg/mL concentrate for solution for infusion EU/1/15/1014/001-004 |
Nivolumab |
Bristol-Myers Squibb Pharma EEIG |
— |
| OPDIVO 600 mg solution for injection EU/1/15/1014/005 |
Nivolumab |
Bristol-Myers Squibb Pharma EEIG |
— |
| Opdualag 240 mg/80 mg sterile concentrate EU/1/22/1679/001 |
RELATLIMAB, Nivolumab |
Bristol-Myers Squibb Pharma EEIG |
— |
| Opfolda 65 mg hard capsules EU/1/23/1737/001-002 |
Miglustat |
Amicus Therapeutics Europe Limited |
— |
| Oprymea 0.088 mg tablets EU/1/08/469/1-5 |
Pramipexole |
KRKA, d.d., Novo mesto |
— |
| Oprymea 0.18 mg tablets EU/1/08/469/6-10 |
Pramipexole |
KRKA, d.d., Novo mesto |
— |
| Oprymea 0.26 mg prolonged-release tablets EU/1/08/469/026-029 |
Pramipexole |
KRKA, d.d., Novo mesto |
— |
| Oprymea 0.35 mg tablets EU/1/08/469/11-15 |
Pramipexole |
KRKA, d.d., Novo mesto |
— |
| Oprymea 0.52 mg prolonged-release tablets EU/1/08/469/030-033 |
Pramipexole |
KRKA, d.d., Novo mesto |
— |
| Oprymea 0.7 mg tablets EU/1/08/469/16-20 |
Pramipexole |
KRKA, d.d., Novo mesto |
— |
| Oprymea 1.05 mg prolonged-release tablets EU/1/08/469/034-037 |
Pramipexole |
KRKA, d.d., Novo mesto |
— |
| Oprymea 1.1 mg tablets EU/1/08/469/21-25 |
Pramipexole |
KRKA, d.d., Novo mesto |
— |
| Oprymea 1.57 mg prolonged-release tablets EU/1/08/469/038-041 |
Pramipexole |
KRKA, d.d., Novo mesto |
— |
| Oprymea 2.1 mg prolonged-release tablets EU/1/08/469/042-045 |
Pramipexole |
KRKA, d.d., Novo mesto |
— |
| Oprymea 2.62 mg prolonged-release tablets EU/1/08/469/046-049 |
Pramipexole dihydrochloride monohydrate |
KRKA, d.d., Novo mesto |
— |
| Oprymea 3.15 mg prolonged-release tablets EU/1/08/469/050-053 |
Pramipexole dihydrochloride monohydrate |
KRKA, d.d., Novo mesto |
— |
| Opsaren 10 mg Film-coated Tablets PA22865/018/001 |
Macitentan |
Renata Pharmaceuticals (Ireland) Limited |
Not marketed |
| Opsumit 10 mg film-coated tablets EU/1/13/893/001-002 |
Macitentan |
Janssen Pharmaceutica NV |
— |
| Opsumit 2.5 mg film-coated tablets EU/1/13/893/004 |
Macitentan |
Janssen Pharmaceutica NV |
— |
| OPTISON 0.19 mg/ml dispersion for injection EU/1/98/065/001 |
Perflutren, Human albumin microspheres |
GE Healthcare AS |
— |
| OPTISON 0.19 mg/ml dispersion for injection EU/1/98/065/002 |
Perflutren, Human albumin microspheres |
GE Healthcare AS |
— |
| Optruma 60 mg film coated tablets EU/1/98/074/001 |
Raloxifene |
Eli Lilly Nederland B.V. |
— |
| Optruma 60 mg film coated tablets EU/1/98/074/002 |
Raloxifene |
Eli Lilly Nederland B.V. |
— |
| Optruma 60 mg film coated tablets EU/1/98/074/003 |
Raloxifene |
Eli Lilly Nederland B.V. |
— |
| Optruma 60 mg film coated tablets EU/1/98/074/004 |
Raloxifene |
Eli Lilly Nederland B.V. |
— |
| Opuviz 40 mg/mL solution for injection in a vial EU/1/24/1865/001-002 |
Aflibercept |
Samsung Bioepis NL B.V. |
— |
| Opzelura 15 mg/g Cream EU/1/23/1726/001 |
Ruxolitinib |
Incyte Biosciences Distribution B.V. |
— |
| Oramox 125 mg/5 ml powder for oral suspension PA1418/013/001 |
Amoxicillin |
Athlone Pharmaceuticals Limited |
Marketed |
| Oramox 250 mg hard capsules PA1418/013/003 |
Amoxicillin |
Athlone Pharmaceuticals Limited |
Marketed |
| Oramox 250 mg/5 ml powder for oral suspension PA1418/013/002 |
Amoxicillin |
Athlone Pharmaceuticals Limited |
Marketed |
| Oramox 500 mg hard capsules PA1418/013/004 |
Amoxicillin |
Athlone Pharmaceuticals Limited |
Marketed |
| Ordspono 2 mg Concentrate for solution for infusion EU/1/24/1843/001 |
Odronextamab |
Regeneron Ireland Designated Activity Company |
— |
| Ordspono 320 mg Concentrate for solution for infusion EU/1/24/1843/003 |
Odronextamab |
Regeneron Ireland Designated Activity Company |
— |
| Ordspono 80 mg Concentrate for solution for infusion EU/1/24/1843/002 |
Odronextamab |
Regeneron Ireland Designated Activity Company |
— |
| Orencia 125 mg solution for injection in pre-filled pen EU/1/07/389/004-009 |
Abatacept |
Bristol-Myers Squibb Pharma EEIG |
— |
| Orencia 125 mg solution for injection in pre-filled pen EU/1/07/389/011-012 |
Abatacept |
Bristol-Myers Squibb Pharma EEIG |
— |
| Orencia 250 mg powder for concentrate for solution for infusion EU/1/07/389/1-3 |
Abatacept |
Bristol-Myers Squibb Pharma EEIG |
— |
| Orencia 50 mg solution for injection in pre-filled syringe EU/1/07/389/013 |
Abatacept |
Bristol-Myers Squibb Pharma EEIG |
— |
| Orencia 87.5 mg solution for injection in pre-filled syringe EU/1/07/389/014 |
Abatacept |
Bristol-Myers Squibb Pharma EEIG |
— |
| ORFADIN EU/1/04/303/1-3 |
Nitisinone |
Swedish Orphan International AB |
— |
| Orfadin 20 mg hard capsules EU/1/04/303/004 |
Nitisinone |
Swedish Orphan Biovitrum AB |
— |
| Orfadin 4 mg/ml oral suspension EU/1/04/303/005 |
Nitisinone |
Swedish Orphan Biovitrum AB |
— |
| Orgalutran 0.25 mg/0.5 mL solution for injection EU/1/00/130/001 |
Ganirelix |
N.V. Organon |
— |
| Orgalutran 0.25 mg/0.5 mL solution for injection EU/1/00/130/002 |
Ganirelix |
N.V. Organon |
— |
| Orgovyx 120 mg film-coated tablets EU/1/22/1642/001 |
Relugolix |
Accord Healthcare S.L.U. |
— |
| Orkambi 100 mg/125 mg film-coated tablets EU/1/15/1059/005 |
Lumacaftor, Ivacaftor |
Vertex Pharmaceuticals (Ireland) Limited |
— |
| Orkambi 100 mg/125 mg granules in sachet EU/1/15/1059/006 |
Lumacaftor, Ivacaftor |
Vertex Pharmaceuticals (Ireland) Limited |
— |
| Orkambi 150 mg/188 mg granules in sachet EU/1/15/1059/007 |
Ivacaftor, Lumacaftor |
Vertex Pharmaceuticals (Ireland) Limited |
— |
| Orkambi 200 mg/125 mg film-coated tablets EU/1/15/1059/001 |
Lumacaftor, Ivacaftor |
Vertex Pharmaceuticals (Ireland) Limited |
— |
| Orkambi 75 mg/94 mg granules in sachet EU/1/15/1059/008 |
Lumacaftor, Ivacaftor |
Vertex Pharmaceuticals (Ireland) Limited |
— |